JNCCN Named as Reference by CMS for Off-Label Coverage Decisions

JENKINTOWN, Pa., October 22, 2007 — JNCCN – The Journal of the National Comprehensive Cancer Network, a peer-reviewed medical journal covering the entire spectrum of oncologic health care, will now be used by the Centers for Medicare & Medicaid Services (CMS) and by its carriers and intermediaries as a mandated reference for off-label use of anti-cancer drugs.

Many common cancer treatments are administered off-label, and evidence for such administration is often found in peer-reviewed medical journals. CMS maintains a list of these journals to be used when decisions are made for the Medicare program about such treatments. Last year, CMS conducted a review of its recommended journal resources and determined that the list should be expanded. JNCCN joins that list effective today, October 22, 2007.

JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology™, review articles elaborating on NCCN Guidelines recommendations and health services and clinical research papers discussing new advances and significant controversies and issues. The journal provides the latest information about best clinical practices, oncology outcomes and new research initiatives. More information on JNCCN, including upcoming editorial calendars and subscription information, can be found at www.nccn.org/jnccn.